Trials / Conditions / Mucopolysaccharidosis VI

Mucopolysaccharidosis VI

18 registered clinical trials studyying Mucopolysaccharidosis VI — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Baby Detect : Genomic Newborn Screening NCT05687474	Centre Hospitalier Universitaire de Liege	—
Recruiting	Registry of Patients Diagnosed With Lysosomal Storage Diseases NCT05619900	University of California, San Francisco	—
Enrolling By Invitation	ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program NCT05368038	Albert Einstein College of Medicine	—
Unknown	Evaluation of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VI NCT03632213	Hospital de Clinicas de Porto Alegre	Phase 2
Completed	A Study in MPS VI to Assess Safety and Efficacy of Odiparcil NCT03370653	Inventiva Pharma	Phase 2
Recruiting	MPS (RaDiCo Cohort) (RaDiCo-MPS) NCT06036693	Institut National de la Santé Et de la Recherche Médicale, France	—
Active Not Recruiting	Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI NCT03153319	Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center	Phase 1 / Phase 2
Completed	Human Placental-Derived Stem Cell Transplantation NCT01586455	New York Medical College	Phase 1
Completed	Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease NCT01707433	Children's Hospitals and Clinics of Minnesota	—
Terminated	Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplas NCT01675674	National MPS Society	—
Terminated	Clinical Trial of Growth Hormone in MPS I, II, and VI NCT00748969	Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center	Phase 2 / Phase 3
Completed	A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI NCT00299000	BioMarin Pharmaceutical	Phase 4
Completed	Study of rhASB in Patients With Mucopolysaccharidosis VI NCT00104234	BioMarin Pharmaceutical	Phase 3
Completed	Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI NCT00067470	BioMarin Pharmaceutical	Phase 3
Completed	Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients Wit NCT00048711	BioMarin Pharmaceutical	Phase 2
Completed	Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI NCT00048620	BioMarin Pharmaceutical	Phase 1
Unknown	Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoie NCT00005900	Fairview University Medical Center	—
Completed	Stem Cell Transplantation for Hurler NCT00176917	Masonic Cancer Center, University of Minnesota	Phase 2